Mariana L. Zahurak - Concepedia

Author

Mariana L. Zahurak

Johns Hopkins University

Also Known As

M. L. Zahurak, M.L Zahurak, M.L. ZAHURAK, M.L. Zahurak, Mariana L Zahurak, Mariana L. Zahurak, Mariana Zahurak

Publications

679

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center University of Chicago

About

Mariana L. Zahurak is an author at Johns Hopkins University specializing in medicine, oncology, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	445
2	Obstetrics	6	6	399
3	Geriatrics	2	2	84
4	Health Sciences	1	1	194
5	Public Health	1	1	22

Mariana L. Zahurak

Publications

667

Citations

H-Index

Page 1

	Year	Citations
Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT Robert E. Bristow, Marcela G. del Carmen, Harpreet K. Pannu, Gynecologic Oncology Secondary Cytoreductive SurgerySurgical OncologyGynecological SurgeryHealth SciencesMedical Imaging	2003	194
Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated Anemia Carole B. Miller, Leonidas C. Platanias, Samuel Mills, JNCI Journal of the National Cancer Institute	1992	83
Recurrent micropapillary serous ovarian carcinoma Robert E. Bristow, Dana R. Gossett, David Shook, Cancer	2002	76
Surgical care of elderly women with ovarian cancer: A population-based perspective Teresa Díaz-Montes, Mariana L. Zahurak, Robert Giuntoli, Gynecologic Oncology Gynecologic SurgerySurgical OncologyGeriatric OncologyGynecological SurgeryOvarian Aging	2005	72
Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma A. Santillan, Y. W. Kim, Mariana L. Zahurak, International Journal of Gynecological Cancer	2007	63
Clinical significance of Her-2/neu overexpression in uterine serous carcinoma Teresa Díaz-Montes, Hongxiu Ji, Ann E. Smith Sehdev, Gynecologic Oncology Uterine Serous CarcinomaTumoral PathologyMedicineGynecologyPathology	2005	62
Micropapillary Serous Ovarian Carcinoma: Surgical Management and Clinical Outcome Robert E. Bristow, Dana R. Gossett, David Shook, Gynecologic Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryGynecologySurgery	2002	37
Abdominal carcinomatosis in women with a history of breast cancer Ruchi Garg, Mariana L. Zahurak, Edward L. Trimble, Gynecologic Oncology Surgical OncologyBreast OncologyMedicinePathologyBreast Cancer	2005	28
Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer Teresa Díaz-Montes, Mariana L. Zahurak, Robert E. Bristow Gynecologic Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryMedicinePostoperative Consideration	2007	22
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action Mario A. Eisenberger, Menachem Laufer, Nicholas J. Vogelzang, Urology UrologyMedicineHormonal ReceptorPharmacologyClinical Pharmacology	2004	18

Page 1